Datasheet | November 30, 2022

Producing Exosome Therapies Efficiently With A Cell Expansion System

Source: Terumo BCT
Exosomes GettyImages-1078208498

Exosome clinical trials are often limited by inefficient manufacturing processes, making clinically relevant doses difficult to obtain. Quantum can efficiently produce large batches of active exosomes from a single donor over a few days. Efficient manufacture in Quantum unlocks the potential of exosome therapies.

Learn about a system researchers are using to expand MSC-derived exosomes and how these exosomes can help treat microvasculature disorders.

access the Datasheet!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene